Analysis of typical characteristics of the hottest

  • Detail

Analysis on the typical characteristics of the development of pharmaceutical packaging in China

pharmaceutical packaging, as a very active branch in the field of packaging in China, its continuous renewal and progress have witnessed the rapid development of the packaging industry. After China's accession to the WTO, more international pharmaceutical enterprises began to enter China. On the one hand, it is usually difficult to return to the original straightness surface, which intensifies the competition in China's pharmaceutical industry. On the other hand, it also improves the quality and technical level of the whole industry, and it is inevitable to drive the development of pharmaceutical packaging. Because the pharmaceutical industry is closely related to the lives of ordinary people, it has created the particularity of pharmaceutical packaging. Therefore, in China, pharmaceutical packaging belongs to the scope of national food and drug administration. But from a technical point of view, the relationship between pharmaceutical packaging and packaging printing is very large, and paying attention to pharmaceutical packaging has become a reason

at present, China's pharmaceutical enterprises are mainly distributed in Jiangsu, Zhejiang and Guangdong. In terms of quantity and scale, pharmaceutical enterprises in Guangdong and Jiangsu and Zhejiang dominate. From the development of the past two years, the large-scale production of pharmaceutical enterprises is becoming more and more obvious, and the grade is also gradually improving. A development trend of modern pharmaceutical enterprises is that larger pharmaceutical factories are equipped with packaging enterprises themselves

at present, the extensive growth with high speed, low efficiency and high consumption is a typical feature of the development of pharmaceutical packaging in China. The packaging quality of most domestic pharmaceutical products is low, and there is still a large gap with developed countries. This can be proved by the following two data. At present, 65% of China's pharmaceutical packaging products are less than international development (2) according to gb/t2039 (1) 997 "experimental methods for tensile creep and durability of metals" (eqviso204:1997), they have reached the national level in the 1980s, and the quality of packaging materials and the contribution rate of packaging to the pharmaceutical industry are low. In developed countries, pharmaceutical packaging accounts for 30% of the value of drugs, while the proportion in China is less than 10%. At present, for the domestic large-scale pharmaceutical packaging enterprises, there is little gap in equipment compared with foreign countries, but the software environment is very unsatisfactory

it is understood that the reasons for this gap are mainly concentrated in three aspects. First, the overall level of China's pharmaceutical industry is relatively low, and the technology of pharmaceutical production enterprises is relatively backward. From the perspective of the scale of pharmaceutical enterprises, China's pharmaceutical enterprises are many and small, the repeated production of drugs is serious, and the management level of pharmaceutical enterprises is low. Secondly, the relevant regulations and technical standards of China's pharmaceutical packaging industry are backward. At present, China has gradually launched the normative standard system of the pharmaceutical industry, but there is still a certain distance from the international standards. The lack of industry standard system leads to the situation that the packaging of pharmaceutical products is neither good nor bad. Finally, there are drawbacks in the drug circulation system. Pharmaceutical products have been mainly sold in hospitals for a long time, and the drugs sold in pharmacies account for only a small part of the total. This situation restricts the direct participation of drugs in market competition and restricts the development of pharmaceutical packaging

in addition, the current drug bidding system has seriously dampened the enthusiasm of pharmaceutical manufacturers. Enterprises cannot make great efforts to reform the packaging, and pharmaceutical packaging has remained old-fashioned for a long time. Based on the above analysis, in addition, the backward technical level of pharmaceutical packaging machinery and materials and the weak quality awareness of practitioners are also factors restricting the development of pharmaceutical product packaging in China

source: HC industry research channel

Copyright © 2011 JIN SHI